Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Computational Chemistry: From the Hydrogen Molecule to Nanostructures Read chapter Read first chapter

2017 | OriginalPaper | Chapter

51. Recent Developments in 3D QSAR and Molecular Docking Studies of Organic and Nanostructures

Author : Bakhtiyor Rasulev

Published in: Handbook of Computational Chemistry

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

The development of quantitative structure–activity relationship (QSAR) methods is going very fast for the last decades. OSAR approach already plays an important role in lead structure optimization, and nowadays, with development of big data approaches and computer power, it can even handle a huge amount of data associated with combinatorial chemistry. One of the recent developments is a three-dimensional QSAR, i.e., 3D QSAR. For the last two decades, 3D-OSAR has already been successfully applied to many datasets, especially of enzyme and receptor ligands. Moreover, quite often 3D QSAR investigations are going together with protein–ligand docking studies and this combination works synergistically. In this review, we outline recent advances in development and applications of 3D QSAR and protein–ligand docking approaches, as well as combined approaches for conventional organic compounds and for nanostructured materials, such as fullerenes and carbon nanotubes.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
previous chapter Unsupervised Learning Methods and Similarity Analysis in Chemoinformatics
next chapter Ontologies in Chemoinformatics
Literature
Ahmed, L., Rasulev, B., Turabekova, M., Leszczynska, D., & Leszczynski, J. (2013). Receptor-and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations. Organic and Biomolecular Chemistry, 11(35), 5798–5808.CrossRef
Ajmani, S., Jadhav, K., & Kulkarni, S. A. (2006). Three-dimensional QSAR using the k-nearest neighbor method and its interpretation. Journal of Chemical Information and Modeling, 46(1), 24–31.CrossRef
Amnerkar, N. D., & Bhusari, K. P. (2010). Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. European Journal of Medicinal Chemistry, 45(1), 149–159.CrossRef
Araújo, J. Q., de Brito, M. A., Hoelz, L. V. B., de Alencastro, R. B., Castro, H. C., Rodrigues, C. R., & Albuquerque, M. G. (2011). Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE). European Journal of Medicinal Chemistry, 46(1), 39–51.CrossRef
Baskin, I. I., & Zhokhova, N. I. (2013). The continuous molecular fields approach to building 3D-QSAR models. Journal of Computer-Aided Molecular Design, 27(5), 427–442.CrossRef
Calvaresi, M., & Zerbetto, F. (2010). Baiting proteins with C60. ACS Nano, 4(4), 2283–2299.CrossRef
Calvaresi, M., & Zerbetto, F. (2011). Fullerene sorting proteins. Nanoscale, 3(7), 2873–2881.CrossRef
Clark, M., Cramer, R. D., Jones, D. M., Patterson, D. E., & Simeroth, P. E. (1990). Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases. Tetrahedron Computer Methodology, 3(1), 47–59.CrossRef
Cramer, R., & Bunce, J. D. (1987). The Dylomms method: Initial results from a comparative study of approaches to 3d QSAR. In Hadzi D., Jerman-Blazic B. (eds) QSAR in drug design and toxicology (pp. 3–12).
Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988). Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. Journal of the American Chemical Society, 110(18), 5959–5967.CrossRef
Cruciani, G., Fontaine, F., & Pastor, M. (2004). Almond; 3.3.0. Perugia: Molecular Discovery Ltd.
Datar, P. A., Khedkar, S. A., Malde, A. K., & Coutinho, E. C. (2006). Comparative residue interaction analysis (CoRIA): A 3D-QSAR approach to explore the binding contributions of active site residues with ligands. Journal of Computer-Aided Molecular Design, 20(6), 343–360.CrossRef
Dhaked, D. K., Verma, J., Saran, A., & Coutinho, E. C. (2009). Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA). Journal of Molecular Modeling, 15(3), 233–245.CrossRef
Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening. 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20, 647–671.CrossRef
Doweyko, A. M. (1988). The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules. Journal of Medicinal Chemistry, 31(7), 1396–1406.CrossRef
Durdagi, S., Mavromoustakos, T., Chronakis, N., & Papadopoulos, M. G. (2008a). Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. Bioorganic and Medicinal Chemistry, 16(23), 9957–9974.CrossRef
Durdagi, S., Mavromoustakos, T., & Papadopoulos, M. G. (2008b). 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. Bioorganic and Medicinal Chemistry Letters, 18(23), 6283–6289.CrossRef
Durdagi, S., Supuran, C. T., Strom, T. A., Doostdar, N., Kumar, M. K., Barron, A. R., Mavromoustakos, T., & Papadopoulos, M. G. (2009). In silico drug screening approach for the design of magic bullets: A successful example with anti-HIV fullerene derivatized amino acids. Journal of Chemical Information and Modeling, 49(5), 1139–1143.CrossRef
Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M. T., McDowell, R. M., & Gramatica, P. (2003). Methods for reliability and uncertainty assessment and for applicability evaluations of classification-and regression-based QSARs. Environmental Health Perspectives, 111(10), 1361.CrossRef
Esposito, E. X., Hopfinger, A. J., Shao, C.-Y., Su, B.-H., Chen, S.-Z., & Tseng, Y. J. (2015). Exploring possible mechanisms of action for the nanotoxicity and protein binding of decorated nanotubes: Interpretation of physicochemical properties from optimal QSAR models. Toxicology and Applied Pharmacology, 288(1), 52–62.CrossRef
Evans, D. A., Doman, T. N., Thorner, D. A., & Bodkin, M. J. (2007). 3D QSAR methods: Phase and catalyst compared. Journal of Chemical Information and Modeling, 47(3), 1248–1257.CrossRef
Fontaine, F., Pastor, M., & Sanz, F. (2004). Incorporating molecular shape into the alignment-free GRid-IN dependent descriptors. Journal of Medicinal Chemistry, 47(11), 2805–2815.CrossRef
Fontaine, F., Pastor, M., Zamora, I., & Sanz, F. (2005). Anchor-GRIND: Filling the gap between standard 3D QSAR and the GRid-IN dependent descriptors. Journal of Medicinal Chemistry, 48(7), 2687–2694.CrossRef
Gohlke, H., & Klebe, G. (2002). DrugScore meets CoMFA: Adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein. Journal of Medicinal Chemistry, 45(19), 4153–4170.CrossRef
Goodford, P. J. (1985). A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. Journal of Medicinal Chemistry, 28(7), 849–857.CrossRef
Gopalakrishnan, B., Aparna, V., Jeevan, J., Ravi, M., & Desiraju, G. (2005). A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models. Journal of Chemical Information and Modeling, 45(4), 1101–1108.CrossRef
Gupta, P., Roy, N., & Garg, P. (2009). Docking-based 3D-QSAR study of HIV-1 integrase inhibitors. European Journal of Medicinal Chemistry, 44(11), 4276–4287.CrossRef
Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5‐6), 490–519.CrossRef
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47, 1750–1759.CrossRef
Hansch, C., Leo, A., Hoekman, D., & Leo, A. (1995). Exploring QSAR. Washington, DC: American Chemical Society.
Hopfinger, A. J. (1980). A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis. Journal of the American Chemical Society, 102(24), 7196–7206.CrossRef
Hu, R., Barbault, F., Delamar, M., & Zhang, R. (2009). Receptor-and ligand-based 3D-QSAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorganic and Medicinal Chemistry, 17(6), 2400–2409.CrossRef
Isayev, O., Rasulev, B., Gorb, L., & Leszczynski, J. (2006). Structure-toxicity relationships of nitroaromatic compounds. Molecular Diversity, 10(2), 233–245.CrossRef
Jha, K. K., Samad, A., Kumar, Y., Shaharyar, M., Khosa, R. L., Jain, J., Kumar, V., & Singh, P. (2010). Design, synthesis and biological evaluation of 1, 3, 4-oxadiazole derivatives. European Journal of Medicinal Chemistry, 45(11), 4963–4967.CrossRef
Karelson, M., Lobanov, V. S., & Katritzky, A. R. (1996). Quantum-chemical descriptors in QSAR/QSPR studies. Chemical Reviews, 96(3), 1027–1044.CrossRef
Kim, K. H. (2001). Thermodynamic aspects of hydrophobicity and biological QSAR. Journal of Computer-Aided Molecular Design, 15(4), 367–380.CrossRef
Kim, K. H., Greco, G., & Novellino, E. (1998). A critical review of recent CoMFA applications. In Kubinyi H., Folkers G., Martin Y.C. (eds) In 3D QSAR in drug design (pp. 257–315). Springer.
Klebe, G. (2006). Virtual ligand screening: Strategies, perspectives and limitations. Drug Discovery Today, 11(13), 580–594.CrossRef
Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37(24), 4130–4146.CrossRef
Kubinyi, H. (1997a). QSAR and 3D QSAR in drug design Part 1: Methodology. Drug Discovery Today, 2(11), 457–467.CrossRef
Kubinyi, H. (1997b). QSAR and 3D QSAR in drug design part 2: Applications and problems. Drug Discovery Today, 2(12), 538–546.CrossRef
Kumar, B. P., Sankar, G., Baig, R. N., & Chandrashekaran, S. (2009). Novel Biginelli dihydropyrimidines with potential anticancer activity: A parallel synthesis and CoMSIA study. European Journal of Medicinal Chemistry, 44(10), 4192–4198.CrossRef
Li, H., Sutter, J., & Hoffmann, R. (2000). HypoGen: An automated system for generating 3D predictive pharmacophore models. In Pharmacophore perception, development, and use in drug design (Vol. 2, p. 171).
Lill, M. A. (2007). Multi-dimensional QSAR in drug discovery. Drug Discovery Today, 12(23), 1013–1017.CrossRef
Lushington, G. H., Guo, J.-X., & Wang, J. L. (2007). Whither combine? New opportunities for receptor-based QSAR. Current Medicinal Chemistry, 14(17), 1863–1877.CrossRef
Martin, Y. C. (2009). Let’s not forget tautomers. Journal of Computer-Aided Molecular Design, 23(10), 693–704.CrossRef
Molecular Operating Environment (MOE). (2016). Chemical Computing Group Inc. 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7.
Moro, S., Braiuca, P., Deflorian, F., Ferrari, C., Pastorin, G., Cacciari, B., Baraldi, P. G., Varani, K., Borea, P. A., & Spalluto, G. (2005). Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: Pyrazolo [4, 3-e] 1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives as a key study. Journal of Medicinal Chemistry, 48(1), 152–162.CrossRef
Moro, S., Bacilieri, M., Cacciari, B., Bolcato, C., Cusan, C., Pastorin, G., Klotz, K.-N., & Spalluto, G. (2006). The application of a 3D-QSAR (autoMEP/PLS) approach as an efficient pharmacodynamic-driven filtering method for small-sized virtual library: Application to a lead optimization of a human A 3 adenosine receptor antagonist. Bioorganic and Medicinal Chemistry, 14(14), 4923–4932.CrossRef
Mozolewska, M. A., Krupa, P., Rasulev, B., Liwo, A., & Leszczynski, J. (2014). Preliminary studies of interaction between nanotubes and toll-like receptors. Task Quarterly, 18(4), 351–355.
Oprea, T. I., & Matter, H. (2004). Integrating virtual screening in lead discovery. Current Opinion in Chemical Biology, 8(4), 349–358.CrossRef
Ortiz, A. R., Pisabarro, M. T., Gago, F., & Wade, R. C. (1995). Prediction of drug binding affinities by comparative binding energy analysis. Journal of Medicinal Chemistry, 38(14), 2681–2691.CrossRef
Pajeva, I. K., Globisch, C., & Wiese, M. (2009). Combined pharmacophore modeling, docking, and 3D QSAR studies of ABCB1 and ABCC1 transporter inhibitors. ChemMedChem, 4(11), 1883–1896.CrossRef
Pastor, M., Cruciani, G., McLay, I., Pickett, S., & Clementi, S. (2000). GRid-INdependent descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. Journal of Medicinal Chemistry, 43, 3233–3243.CrossRef
Patel, P. D., Patel, M. R., Kaushik-Basu, N., & Talele, T. T. (2008). 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors. Journal of Chemical Information and Modeling, 48(1), 42–55.CrossRef
Perkins, R., Fang, H., Tong, W., & Welsh, W. J. (2003). Quantitative structure‐activity relationship methods: Perspectives on drug discovery and toxicology. Environmental Toxicology and Chemistry, 22(8), 1666–1679.CrossRef
Perola, E. (2006). Minimizing false positives in kinase virtual screens. Proteins: Structure, Function, and Bioinformatics, 64(2), 422–435.CrossRef
Podlogar, B. L., & Ferguson, D. M. (2000). QSAR and CoMFA: A perspective on the practical application to drug discovery. Drug Design and Discovery, 17(1), 4.
Polanski, J., Gieleciak, R., & Bak, A. (2002). The comparative molecular surface analysis (CoMSA)-a nongrid 3D QSAR method by a coupled neural network and PLS system: Predicting p K a values of benzoic and alkanoic acids. Journal of Chemical Information and Computer Science, 42(2), 184–191.CrossRef
Polanski, J., Bak, A., Gieleciak, R., & Magdziarz, T. (2006). Modeling robust QSAR. Journal of Chemical Information and Modeling, 46(6), 2310–2318.CrossRef
Pulla, V. K., Sriram, D. S., Viswanadha, S., Sriram, D., & Yogeeswari, P. (2016). Energy-based pharmacophore and three-dimensional quantitative structure–activity relationship (3D-QSAR) modeling combined with virtual screening to identify novel small-molecule inhibitors of silent mating-type information regulation 2 homologue 1 (SIRT1). Journal of Chemical Information and Modeling, 56(1), 173–187.CrossRef
Puzyn, T., Rasulev, B., Gajewicz, A., Hu, X., Dasari, T. P., Michalkova, A., Hwang, H.-M., Toropov, A., Leszczynska, D., & Leszczynski, J. (2011). Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nature Nanotechnology, 6(3), 175–178.CrossRef
Ragno, R., Artico, M., De Martino, G., La Regina, G., Coluccia, A., Di Pasquali, A., & Silvestri, R. (2005). Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl) carboxamide and N-(2-hydroxyethyl) carbohydrazide derivatives. Journal of Medicinal Chemistry, 48(1), 213–223.CrossRef
Raparti, V., Chitre, T., Bothara, K., Kumar, V., Dangre, S., Khachane, C., Gore, S., & Deshmane, B. (2009). Novel 4-(morpholin-4-yl)-N′-(arylidene) benzohydrazides: Synthesis, antimycobacterial activity and QSAR investigations. European Journal of Medicinal Chemistry, 44(10), 3954–3960.CrossRef
Rasulev, B., Kušić, H., Leszczynska, D., Leszczynski, J., & Koprivanac, N. (2010). QSAR modeling of acute toxicity on mammals caused by aromatic compounds: The case study using oral LD 50 for rats. Journal of Environmental Monitoring, 12(5), 1037–1044.CrossRef
Ravichandran, V., Kumar, B. P., Sankar, S., & Agrawal, R. (2009). Predicting anti-HIV activity of 1, 3, 4-thiazolidinone derivatives: 3D-QSAR approach. European Journal of Medicinal Chemistry, 44(3), 1180–1187.CrossRef
Robinson, D. D., Winn, P. J., Lyne, P. D., & Richards, W. G. (1999). Self-organizing molecular field analysis: A tool for structure-activity studies. Journal of Medicinal Chemistry, 42(4), 573–583.CrossRef
Saikia, N., Rajkhowa, S., & Deka, R. C. (2013). Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein. Journal of Computer-Aided Molecular Design, 27(3), 257–276.CrossRef
Sakkiah, S., Thangapandian, S., John, S., Kwon, Y. J., & Lee, K. W. (2010). 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors. European Journal of Medicinal Chemistry, 45(6), 2132–2140.CrossRef
Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2005). PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Research, 33(Suppl 2), W363–W367.CrossRef
Shih, K.-C., Lin, C.-Y., Zhou, J., Chi, H.-C., Chen, T.-S., Wang, C.-C., Tseng, H.-W., & Tang, C.-Y. (2011). Development of novel 3D-QSAR combination approach for screening and optimizing B-Raf inhibitors in silico. Journal of Chemical Information and Modeling, 51(2), 398–407.CrossRef
Silverman, B., & Platt, D. E. (1996). Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. Journal of Medicinal Chemistry, 39(11), 2129–2140.CrossRef
Sun, J., Cai, S., Yan, N., & Mei, H. (2010). Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis. European Journal of Medicinal Chemistry, 45(3), 1008–1014.CrossRef
Taha, M. O., Dahabiyeh, L. A., Bustanji, Y., Zalloum, H., & Saleh, S. (2008). Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. Journal of Medicinal Chemistry, 51, 6478–6494.CrossRef
Todeschini, R., & Gramatica, P. (1998). 3D QSAR in drug design (Vol. 2, pp. 355–360). Dordrecht: Kluwer/ESCOM.CrossRef
Totrov, M. (2008). Atomic property fields: Generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR. Chemical Biology and Drug Design, 71(1), 15–27.CrossRef
Tripos. (2006). SYBYL, version 7.3, 2006, St, Louis.
Turabekova, M., Rasulev, B., Theodore, M., Jackman, J., Leszczynska, D., & Leszczynski, J. (2014). Immunotoxicity of nanoparticles: A computational study suggests that CNTs and C 60 fullerenes might be recognized as pathogens by Toll-like receptors. Nanoscale, 6(7), 3488–3495.CrossRef
Tzoupis, H., Leonis, G., Durdagi, S., Mouchlis, V., Mavromoustakos, T., & Papadopoulos, M. G. (2011). Binding of novel fullerene inhibitors to HIV-1 protease: Insight through molecular dynamics and molecular mechanics Poisson–Boltzmann surface area calculations. Journal of Computer-Aided Molecular Design, 25(10), 959–976.CrossRef
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623.CrossRef
Virsodia, V., Pissurlenkar, R. R., Manvar, D., Dholakia, C., Adlakha, P., Shah, A., & Coutinho, E. C. (2008). Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1, 2, 3, 4-tetrahydro-pyrimidine-5-carboxamides. European Journal of Medicinal Chemistry, 43(10), 2103–2115.CrossRef
Walters, D. E., & Hinds, R. M. (1994). Genetically evolved receptor models: A computational approach to construction of receptor models. Journal of Medicinal Chemistry, 37(16), 2527–2536.CrossRef
Wang, Y.-C., Chen, S.-L., Deng, N.-Y., & Wang, Y. (2016). Computational probing protein–protein interactions targeting small molecules. Bioinformatics, 32(2), 226–234.
Wise, M., Cramer, R. D., Smith, D., & Exman, I. (1983). Progress in three-dimensional drug design: The use of real-time colour graphics and computer postulation of bioactive molecules in DYLOMMS. Amsterdam: Elsevier.
Yang, S.-Y. (2010). Pharmacophore modeling and applications in drug discovery: Challenges and recent advances. Drug Discovery Today, 15(11), 444–450.CrossRef
Yang, Y., Qin, J., Liu, H., & Yao, X. (2011). Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors. Journal of Chemical Information and Modeling, 51(3), 680–692.CrossRef
Zhokhova, N. I., Baskin, I. I., Bakhronov, D. K., Palyulin, V. A., & Zefirov, N. S. (2009). Method of continuous molecular fields in the search for quantitative structure-activity relationships. Doklady Chemistry, 429(1), 273–276.CrossRef
Zhou, P., Tian, F., & Li, Z. (2007). Three dimensional holographic vector of atomic interaction field (3D-HoVAIF). Chemometrics and Intelligent Laboratory Systems, 87(1), 88–94.CrossRef
Metadata
Title
Recent Developments in 3D QSAR and Molecular Docking Studies of Organic and Nanostructures
Author
Bakhtiyor Rasulev
Copyright Year
2017
Book
Handbook of Computational Chemistry

Print ISBN: 978-3-319-27281-8

Electronic ISBN: 978-3-319-27282-5

Copyright Year: 2017

DOI
https://doi.org/10.1007/978-3-319-27282-5_54

Premium Partner

    Image Credits